Page last updated: 2024-08-25

zoledronic acid and Uterine Cervical Dysplasia

zoledronic acid has been researched along with Uterine Cervical Dysplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giraudo, E; Hanahan, D; Inoue, M	1

Other Studies

1 other study(ies) available for zoledronic acid and Uterine Cervical Dysplasia

Article	Year
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. The Journal of clinical investigation, 2004, Volume: 114, Issue:5 Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Diphosphonates; Enzyme Activation; Female; Humans; Imidazoles; Macrophage Activation; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Transgenic; Neovascularization, Pathologic; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factors; Zoledronic Acid	2004

Article

Year

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

The Journal of clinical investigation, 2004, Volume: 114, Issue:5

Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Diphosphonates; Enzyme Activation; Female; Humans; Imidazoles; Macrophage Activation; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Transgenic; Neovascularization, Pathologic; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factors; Zoledronic Acid

2004